Leonurine Attenuates CCl4-Induced Hepatic Fibrosis in Mice via the Hippo-YAP Pathway
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s518793 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Pengru Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Hepatobiliary and Pancreatic Diseases Key Laboratory of Luzhou City, Academician (Expert) Workstation of Sichuan Province, the Affiliated H…. Hauptthemen laut MEDLINE: Liver Cirrhosis, Gallic Acid, Protein Serine-Threonine Kinases, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Metabolic Hepatobiliary and Pancreatic Diseases Key Laboratory of Luzhou City, Academician (Expert) Workstation of Sichuan Province, the Affiliated Hospital, Southwest Medical University, Luzhou, 646000, People's Republ…
- Department of General Surgery (Hepatopancreatobiliary Surgery), the Affiliated Hospital, Southwest Medical University, Luzhou, 646000, People's Republic of China.
- Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.
- Drug Clinical Trial Institution, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, People's Republic of China.
- Clinical Medical Research Center, the Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.
- Department of Gastroenterology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
ORCID-Profile: Pengru Wang, Zhiwei Huang
Zitieren
APA
Wang, P., Bai, J., Ye, M., Huang, Z., Chen, J., Sun, L., Zhong, X., Zheng, Y., Ma, T., Fu, W., & Du, Y. (2025). Leonurine Attenuates CCl4-Induced Hepatic Fibrosis in Mice via the Hippo-YAP Pathway. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s518793
Vancouver
Wang P, Bai J, Ye M, Huang Z, Chen J, Sun L, et al. Leonurine Attenuates CCl4-Induced Hepatic Fibrosis in Mice via the Hippo-YAP Pathway. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s518793
BibTeX
@article{Wang2025,
author = {Wang, Pengru and Bai, Junjie and Ye, Mingxin and Huang, Zhiwei and Chen, Jiatong and Sun, Lei and Zhong, Xiaolin and Zheng, Yang and Ma, Tingting and Fu, Wenguang and Du, Yichao},
title = {Leonurine Attenuates CCl4-Induced Hepatic Fibrosis in Mice via the Hippo-YAP Pathway},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s518793}
}
EUVIMED